FTC Stops Proposed Merger of Leading Cataract-Surgery Device Makers

Deal threatened to raise prices and reduce innovation for cataract laser eye surgery systems, impacting surgeons and millions of American patients

In response to the announcement that Alcon, Inc. and Alcon Research, LLC (collectively referred to as Alcon) has abandoned its efforts to purchase LENSAR, Inc. (Lensar), Federal Trade Commission Bureau of Competition Director Daniel Guarnera issued the following statement: 

View Press Release


Source link